Pharmagreen Biotech Inc. (PHBI)
OTC Markets OTCID
Price as at 30 Sept 2026, 23:36 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
Pharmagreen Biotech Inc. trades at $0.33. We do not hold enough of the inputs to value this company with the confidence the estimate implies, so we publish no fair value for it rather than a number we would not defend.
About Pharmagreen Biotech Inc.
Pharmagreen Biotech Inc. operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America. The company's primary product is MaxGenomic supplement, a proprietary blend and formulated medicinal mushrooms and medical plants to support the human mind and body. It also provides consulting services for plant genetic selection, tissue culture technologies for starter plantlets production, SOPs for cultivation and live storage of any plant species services. It sells its products through online stores, such as Amazon and Shopify. Pharmagreen Biotech Inc. is headquartered in Coquitlam, Canada.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
Common questions
Where does SteadyShares get its PHBI data?
Fundamentals for PHBI come from company filings and exchange data, as listed on OTC Markets OTCID; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 30 Sept 2026, 23:36 UTC and is delayed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for PHBI, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.